US Broker Ratings

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 25.59% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (AZN), a titan in the healthcare sector, has garnered significant attention from investors, offering a potential upside of 25.59% as per recent analyst evaluations...

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with Strong Buy Ratings and 11% Potential Upside

Jazz Pharmaceuticals plc (JAZZ), a leading player in the biotechnology sector, continues to capture investor interest with its promising growth trajectory and robust product pipeline. Headquartered..

Atrium Therapeutics (RNA): Exploring the 102% Upside Potential in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing investor attention with its promising focus on RNA-based therapeutics targeting cardiomyopathies. This San Diego-based biopharmaceutical company is pioneering innovative..

Bruker Corporation (BRKR): An Investor’s Insight into Healthcare’s Hidden Gem with Potential Growth

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is carving a niche in the medical devices industry. With its headquarters in Billerica, Massachusetts,..

BioNTech SE (BNTX) Investor Outlook: Potential 36.52% Upside Amidst Growing Immunotherapy Portfolio

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, commands significant attention from investors owing to its pivotal role in developing cutting-edge immunotherapies. With..

Alkermes plc (ALKS) Stock Analysis: Growth Potential with a 28.20% Revenue Surge

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its specialty and generic pharmaceutical offerings...

Cytokinetics, Inc. (CYTK) Stock Analysis: Tapping into a Potential 49% Upside in the Biotech Sector

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical leader in the healthcare sector, is capturing investor attention with its promising pipeline of novel muscle activators and inhibitors. As..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Biotech Gem with 41% Upside Potential

Investors in the biotechnology sector may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing proposition, particularly given its focus on addressing metabolic dysfunction-associated steatohepatitis (MASH) with..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 57% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is carving out a notable position in the healthcare sector, particularly within the medical devices industry. Headquartered in San Francisco, California,..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthy 47.55% Upside Potential In Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, particularly in medical care facilities, stands out with its robust growth potential. With..

Glaukos Corporation (GKOS) Stock Analysis: A 23% Upside Potential in the Booming Medical Device Market

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, has been capturing investor attention with its innovative solutions in the medical devices industry. As..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus Reveals a Striking 118.65% Potential Upside

Telix Pharmaceuticals Limited (TLX), a leading player in the biopharmaceutical sector, is gaining traction among investors due to its promising pipeline and significant growth potential. Headquartered..

Legend Biotech Corporation (LEGN): Investor Outlook with 60.57% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biopharmaceutical landscape with its impressive growth potential and innovative approach to oncology therapeutics. As a prominent player..

Viatris Inc. (VTRS) Stock Analysis: Navigating Growth Prospects with an 8.09% Potential Upside

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is making waves in the stock market with its recent performance and growth potential. Operating within..

Novo Nordisk A/S (NVO) Stock Analysis: Assessing Growth Potential and Dividend Attraction

Novo Nordisk A/S (NVO), a dominant player in the global healthcare sector, continues to make significant strides in the drug manufacturing industry. With a robust market..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth with a 7.98% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) presents a compelling opportunity for investors keen on the healthcare sector, specifically within biotechnology. With a robust market capitalization of $31.6..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX): Investor Outlook on a Medical Device Innovator with a 60.17% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), with a market capitalization of $2.52 billion, stands at the forefront of transforming organ transplant therapy. Known for its pioneering Organ..

Quest Diagnostics Incorporated (DGX) Stock Analysis: A 10% Upside Potential for Investors

For investors seeking opportunities in the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing prospect. With a market capitalization of $22.48 billion, Quest Diagnostics..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds